跳至主要内容
临床试验/JPRN-UMIN000042603
JPRN-UMIN000042603尚未招募未知

The Multicenter Prospective Randomized Controlled Trial Evaluating Efficacy of Dapagliflozin to Improve Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure - DARAF trial

Showa University Northern Yokohama Hospital0 个研究点目标入组 200 人开始时间: 2020年11月30日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who are intolerant for SGLT-2 inhibitor Patients with renal insufficiency (estimated GFR < 30) When the attending physician consider inappropriate to enroll the patient in the study

研究者

发起方
Showa University Northern Yokohama Hospital

相似试验

The Multicenter Prospective Randomized Controlled... | 临床试验